Back to Authors

Petranović, Milena

https://orcid.org/0000-0002-6412-7428

Mayo Clinic

Massachusetts General Hospital

Citations 4

1236 Machine learning-based clinico-genomic prediction of benefits to add chemotherapy to immunotherapy in metastatic non-small cell lung cancer
Saad, Maliazurina B. , Hong, Lingzhi , Boiarsky, Daniel , Li, Shenduo , Petranović, Milena , Cascone, Tina , Le, Xiuning, Chang, Joe H. , Vaporciyan, Ara A. , Lee, J Jack, Mirjalili, Sayedali, Gainor, Justin F. , Lou, Yanyan , DiFederico, Alessandro, Pecci, Federica , Wu, Jia, Al-Tashi, Qasem , Li, Wentao , Wu, Carol C. , Carter, Brett, Gibbons, Don L , Lee, J Jack, Mirjalili, Sayedali, Jaffray, David A. , Ricciuti, Biagio , Awad, Mark M. , Heymach, John V. , Vokes, Natalie I. , Zhang, Jianjun

Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1379-A1380

10.1136/jitc-2024-sitc2024.1236 Get It

U.S. Newspaper Coverage of Lung Cancer Screening From 2010 to 2022
Zippi, Zachary , Cortopassi, Isabel O. , Johnson, Elizabeth , McDermott, Shaunagh , Mergo, Patricia J. , Petranović, Milena , Price, Melissa C. , Stowell, Justin T. , Little, Brent P.

American Journal of Roentgenology | April 25, 2023 | Volume: 221 | Issue: 2 | Pages: 258-271

10.2214/ajr.23.29066 Get It

Factors affecting patient adherence to lung cancer screening: A multisite analysis
Stowell, Justin T. , Wang, Gary X. , Fintelmann, Florian J. , Flores, Efrén J. , Petranović, Milena , Shepard, Jo-Anne O. , Flores, Efren J , Narayan, Anand K. , Sharma, Amita , Little, Brent P.

Journal of Medical Screening | August 27, 2020 | Volume: 28 | Issue: 3 | Pages: 357-364

10.1177/0969141320950783 Get It

Objective To identify factors associated with delayed adherence to follow-up in lung cancer screening. Methods Utilizing a data warehouse and lung cancer screening registry, variables were collected from a referred sample of 3110 unique participants with follow-up CT during the study period (1 January 2016 to 17 October 2018). Adherence was defined as undergoing chest CT within 90 days and 30 days of the recommended time for follow-up and was determined using proportions and multiple variable logistic regression models across the American College of Radiology Lung Imaging Reporting and Data System (Lung-RADS®) categories. Results Of 1954 lung cancer screening participants (51.9% (1014/1954) males, 48.1% (940/1954) female; mean age 65.7 (range 45–87), smoking history median 40 pack-years, 60.2% and 44.5% did not follow-up within 30 and 90 days, respectively. Participants receiving Lung-RADS® category 1 or 2 presented later than those with Lung-RADS® category 3 at 90 days (coefficient −27.24, 95% CI −51.31, −3.16, p = 0.027). Participants with Lung-RADS® category 1 presented later than those with Lung-RADS® category 2 at both 90- and 30-days past due (OR 0.76 95% CI [0.59–0.97], p = 0.029 and OR 0.63 95% CI [0.48–0.83], p = 0.001, respectively). Conclusions Adherence to follow-up was higher among participants receiving more suspicious Lung-RADS® results at index screening CT and among those who had undergone more non-lung cancer screening imaging examinations prior to index lung cancer screening CT. These observations may inform strategies aimed at prospectively identifying participants at risk for delayed or nonadherence to prevent potential morbidity and mortality from incident lung cancers.
Evaluation of the Informational Content and Readability of US Lung Cancer Screening Program Websites
Gagne, Staci , Fintelmann, Florian J. , Flores, Efrén J. , McDermott, Shaunagh , Mendoza, Dexter P. , Petranović, Milena , Price, Melissa C. , Stowell, Justin T. , Flores, Efren J , Little, Brent P.

JAMA Network Open | January 31, 2020 | Volume: 3 | Issue: 1 | Pages: e1920431

10.1001/jamanetworkopen.2019.20431 Get It